Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
A French research trial aims to assemble a biological collection to develop preclinical translational models for tumors and chronic liver di…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat [Phase 1]
A Phase 1 clinical trial update for a potential new medicine (NNC4005-0001) under development by Novo Nordisk to treat fatty liver disease i…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Tocotrienol Against the Progression of End Stage Liver Disease [Phase 2]
Phase 2 clinical trial evaluating tocotrienol to slow progression of end-stage liver disease, including nonalcoholic steatohepatitis and non…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Integrated Diagnostics for Early Diagnosis of Liver Disease
This clinical trial entry reports that a study on integrated diagnostics for early detection of liver disease is currently recruiting, evalu…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Ketotifen in Non-Alcoholic Fatty Liver Disease Patients [Phase 4]
Ketotifen was studied in patients with non-alcoholic fatty liver disease in a Phase 4 trial. The study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Human Models of Selective Insulin Resistance: Pancreatic Clamp [Phase 1]
A Phase 1 clinical trial from Columbia University examining human models of selective insulin resistance. The study targets insulin resistan…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia [Phase 2]
A Phase 2 trial evaluating MN-001 in patients with non-alcoholic fatty liver disease and comorbid type 2 diabetes mellitus and hypertriglyce…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLD [NA]
This trial update reports the completion of a study evaluating the effect of the probiotic L. lactis CKDB001 on liver aminotransferase level…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Duodenal ReCET as an Early Treatment for Type 2 DM [NA]
A clinical trial update describes evaluating a duodenal ReCET procedure as an early treatment for type 2 diabetes mellitus, with the study n…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study [NA]
A Phase 2 pediatric pilot trial evaluating liver fat quantification (LFQ) has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Milk Thistle Clinical Trial in Pediatric NAFLD [Phase 2]
A Phase 2 clinical trial evaluating milk thistle in pediatric non-alcoholic fatty liver disease is currently recruiting, sponsored by Univer…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
This clinical trial update reports on the prevalence and factors predicting hepatic steatosis in persons living with HIV.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study [NA]
A completed pilot trial evaluating ultrasound-based liver fat quantification for non-alcoholic fatty liver disease and non-alcoholic steatoh…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease [Phase 2]
Clinical trial update for a Phase 2 study investigating how SGLT2 inhibition may affect pediatric non-alcoholic fatty liver disease. The tri…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease [Phase 2]
A Phase 2 clinical trial is investigating SGLT2 inhibitors as a potential treatment for pediatric Non-Alcoholic Fatty Liver Disease; the stu…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: The Olmsted NAFLD Epidemiology Study (TONES) [NA]
ClinicalTrials.gov entry for the Olmsted NAFLD Epidemiology Study (TONES) shows the study is currently recruiting participants for non-alcoh…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease [NA]
A completed study compared the effects of aspirin versus SGLT2 inhibitors on liver enzymes, lipid profile, and FibroScan findings in individ…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Pancreatic Clamp in NAFLD [Phase 1]
Phase 1 clinical trial evaluating a pancreatic clamp approach in non-alcoholic fatty liver disease to study insulin resistance and related m…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Glycemic Effect of Diazoxide in NAFLD [Phase 1]
A Phase 1 study evaluating the glycemic effects of diazoxide in individuals with hyperinsulinemia, insulin resistance, prediabetes, and non-…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease [Phase 2]
A Phase 2 clinical trial is evaluating Longqi Jiangzhi Decoction for non-alcoholic fatty liver disease and is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) [Phase 2]
A Phase 2 clinical trial at Ain Shams University evaluating rutin and vitamin C for metabolic dysfunction-associated steatotic liver disease…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"
This completed trial assesses the diagnostic accuracy of LLIFT, a novel non-invasive biomarker, for diagnosing non-alcoholic fatty liver dis…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease [NA]
This entry describes a clinical trial evaluating whether lifestyle interventions can influence cognitive decline in non-alcoholic fatty live…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology. [NA]
A completed clinical trial (sponsored by Hospices Civils de Lyon) evaluating screening for NAFLD-related advanced fibrosis in a high-risk di…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Saroglitazar Magnesium 4 mg in the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Women With PCOS (EVIDENCES VII) [Phase 2]
Phase 2 trial of Saroglitazar Magnesium 4 mg for non-alcoholic fatty liver disease in women with polycystic ovary syndrome (PCOS) was termin…